Shorted
Ceryvyn Therapeutics logo
CYV
Pharmaceuticals, Biotechnology & Life Sciences

Ceryvyn Therapeutics

Short interest
0.23%
−0.05 pp 30d
as of 7 Oct 2026
Reported shorts
3.2M
Shares on issue
1.368B

Ceryvyn Therapeutics (CYV) News

Latest articles and price-sensitive announcements with AI sentiment classification.

Kalkine
Neutral
14 Sept

Ceryvyn Therapeutics Grants 7 Million Unquoted Options Expiring November 2029 at $0.02 Exercise Price

Ceryvyn Therapeutics Limited (ASX:CYV) announced the issuance of 7,000,000 unquoted options on 11 September 2026. These options, expiring on 11 November 2029 with an exercise price of AUD $0.02, were granted as compensation for investor, public relations, and corporate strategy services instead of cash payments. Key Points On 11 September 2026, Ceryvyn Therapeutics issued 7,000,000 unquoted options expiring 11 November 2029, exercisable at AUD $0.02. The options were issued as non-cash consid...

Continue reading
Kalkine
Neutral
1 Sept

Ceryvyn Therapeutics to Grant 7 Million Unlisted Options as Payment for Advisory Services

Ceryvyn Therapeutics Limited (ASX:CYV) has announced plans to issue 7,000,000 unlisted options to an investor and advisor specializing in public relations and corporate strategy as compensation for services instead of cash payments, with the issuance set for 11 September 2026. Key Points 7,000,000 unlisted options scheduled for issuance on 11 September 2026 Options feature an exercise price of AUD $0.02 and expire on 11 November 2029 Securities issued as remuneration for investor relations, p...

Continue reading